Male Genital Care in Boys — Retraction, Cleaning, and When to See a Doctor

Lead

Genital care for boys is an area where the advice parents receive tends to be contradictory. "You should retract it." "You shouldn't touch it." "The pediatrician said one thing; the hospital nurse said another." Both of these positions exist simultaneously in clinics, maternity wards, and across the internet — which makes it genuinely difficult to know what to do.

This is not simply a communication failure. The two positions reflect a real evidence dispute, and the weight of evidence is not symmetric between them. The mainstream position in peer-reviewed pediatric urology holds that asymptomatic physiological phimosis requires no intervention. In Japan, however, a practice of gradual retraction — encouraging parents to gently retract the foreskin a little further at each bath — is also widely taught by some surgeons, pediatricians, and maternity units. This article takes the mainstream position as its primary stance while presenting the reasoning and limitations of the other.

Physiological Phimosis Is Not a Disease

Nearly all newborn boys are born with the glans covered by the foreskin. This is called physiological phimosis, and it is not a pathological condition [1,2]. The inner surface of the foreskin is naturally adherent to the glans at birth; over time — through intermittent erections and gradual keratinization of the inner epithelium — those adhesions separate spontaneously [1]. The process takes years and follows its own timetable.

Reported rates of non-retractability by age are consistent across longitudinal studies:

Data from Danish [1], Taiwanese [3], and Japanese [4] longitudinal studies are broadly consistent: by puberty, more than 99% of boys achieve full retraction without any intervention. The Japanese cohort study by Kayaba et al. (n=603) confirmed the same pattern in Japanese boys specifically [4].

Basic Care — "Don't Retract; Wash the Outside"

The mainstream clinical position is simple: asymptomatic physiological phimosis requires no intervention. In practice, this means:

• Do not forcibly retract the foreskin. Retraction that causes pain should not be attempted.
• Wash the outside only with warm water. A small amount of mild, unscented soap is acceptable; it is not necessary.
• After washing, pat dry gently.
• Ballooning — the temporary ballooning of the foreskin during urination — is physiological. If urination is not impaired, no intervention is needed.

Forced retraction carries documented risks [5,6,7]:

• Scarring phimosis — small tears at the preputial ring can heal into scar tissue, converting physiological phimosis into a pathological condition
• Paraphimosis — a retracted foreskin that cannot be reduced back over the glans; a vascular emergency (discussed below)
• Bleeding
• Psychological distress

Major pediatric centers in the United States and United Kingdom — including Boston Children's Hospital, UCSF, and Massachusetts General Hospital — and the British Association of Paediatric Surgeons (BAPS) all state clearly that forced retraction is not recommended [5,6,8]. The Japanese Society of Pediatric Urology takes the same position, defining surgical intervention criteria as limited to medical indications such as paraphimosis or pathological (scarring) phimosis [9].

The Gradual Retraction Approach Practiced in Japan

In Japan, a different approach is widely taught in some clinical settings: during bath time, parents are advised to gently retract the foreskin just a little further each time — without forcing it — aiming first for enough retraction to see the urethral meatus, then maintaining that level of retraction to prevent re-adherence and to keep the area clean. The rationale offered is:

• Achieving partial retraction sufficient to see the meatus (not full retraction)
• Once achieved, maintaining it with regular retraction to prevent re-adhesion
• Reducing the risk of recurrent balanoposthitis and ballooning

This approach has a following among some Japanese pediatric surgeons and pediatricians, and it represents a clinically practiced position. However, there is no RCT-level evidence for its effectiveness. No high-quality prospective trial has compared a retraction-practice group against a no-intervention group; the basis for the recommendation rests primarily on mechanistic reasoning ("retraction prevents re-adhesion," "easier to keep clean at home") and clinical experience.

The two main points of disagreement with the mainstream position are:

1. Whether to intervene in asymptomatic boys — mainstream: no; gradual retraction approach: yes, preventively
2. How to weigh the risks of retraction practice — mainstream: prioritizes the risk of scarring phimosis and paraphimosis; gradual retraction approach: holds that "gentle, within the limits of what's painless" is safe

This article follows the mainstream position. That said, the choice of approach in practice is one parents and caregivers can reasonably discuss with their own pediatrician. One point is unambiguous and shared by both positions: forceful, aggressive retraction is not endorsed by either side.

Balanoposthitis and the "Infections If You Don't Retract" Concern

The argument that "if you don't retract, infections will develop" is one of the main reasons the gradual retraction approach is advocated. This claim is partially, but not fully, correct.

Balanoposthitis (inflammation of the glans and foreskin) occurs in approximately 6% of uncircumcised boys and peaks in incidence between ages two and five [10,11]. Physiological phimosis and smegma accumulation are associated factors — but forced retraction and irritation from soap or detergent are also major causes [11,12]. The causation runs in both directions: not retracting can contribute to inflammation, and retracting (or over-cleaning) can also contribute.

Clinically, the management is straightforward:

• A first, mild episode typically resolves with sitz baths (soaking the lower body in warm water) and a low-potency topical corticosteroid [12]
• Recurrent episodes (two or more) warrant referral to a pediatric urologist [12]
• Recurrent balanitis is a risk factor for pathological phimosis

The primary preventive measure is keeping the outside clean and avoiding irritants (harsh soap, over-washing). The evidence base for placing retraction practice as a preventive strategy is thin.

When to Seek Medical Attention

The following are agreed-upon indications regardless of which care approach a family follows.

Urgent — seek care immediately

• Paraphimosis: A retracted foreskin that has become trapped behind the glans and cannot be reduced. The glans swells and turns purple to dark red; this is painful and represents a vascular emergency requiring immediate emergency care [5,6].
• Obvious urinary obstruction: Complete or near-complete inability to urinate, or urination accompanied by severe pain.

Soon — make an appointment

• Balanoposthitis recurring two or more times
• White, hardened scarring visible at the preputial ring (raises concern for balanitis xerotica obliterans / BXO — an important differential diagnosis for prepubertal pathological phimosis [13])
• Redness, swelling, or discharge that does not improve

No visit needed — physiological

• Ballooning during urination (if urination itself is unimpaired)
• A white, doughy swelling visible under the foreskin — this is a smegma cyst, a normal finding during the spontaneous separation process
• Inability to retract before puberty, in the absence of symptoms

Medical Intervention — Topical Corticosteroids and Circumcision

When symptoms arise or pathological phimosis is confirmed, two treatment approaches are standard.

First-line: Topical corticosteroid therapy

Corticosteroid ointments — such as betamethasone (0.05–0.1%), mometasone, or hydrocortisone — are applied to the preputial ring once or twice daily for four to eight weeks.

A 2025 network meta-analysis (17 RCTs, n=2,057) found that low, medium, and high-potency corticosteroids all improved retractability significantly compared with placebo (RR 2.68–3.19), with no significant difference in efficacy across potency levels [14]. A 2021 meta-analysis reached the same conclusion; adverse events were minimal [15].

In other words, many cases that might otherwise require circumcision can be resolved with topical corticosteroid treatment. This is, however, a treatment to be prescribed and monitored by a physician — it should not be self-administered using over-the-counter preparations. Assessing whether scarring is present, ruling out BXO, and determining the site and duration of application are decisions for a specialist.

Second-line: Circumcision

Circumcision is indicated when corticosteroid therapy fails, in cases of confirmed BXO, recurrent balanoposthitis, and recurrent paraphimosis [8,9]. In Japan, this is typically performed under general anesthesia as a day procedure.

Circumcision performed for cultural or religious reasons — including neonatal circumcision common in some regions and traditions — is outside the scope of this article. The position taken here, consistent with the Japanese Society of Pediatric Urology and most European and Asian pediatric urology bodies, is that circumcision without medical indication is not routinely recommended in childhood [9]. Readers in settings where neonatal circumcision is the cultural or religious norm — including families in the United States, or those observing Jewish or Islamic traditions — should consult their local pediatric or religious authorities; the considerations involved in that decision extend well beyond what this article addresses and are not evaluated here.

Why Corticosteroids Work on a Non-Inflammatory Condition — A Mechanistic Note

Readers familiar with corticosteroids as anti-inflammatory medications may find this puzzling: physiological phimosis is not an inflammatory condition, so why do steroids help?

The mechanism is not fully established, but two parallel pathways are proposed [16,17].

Mechanism 1: Anti-inflammatory action

Corticosteroids inhibit phospholipase A2 via lipocortin induction, blocking the arachidonic acid pathway to prostaglandins and leukotrienes. This reduces edema, suppresses leukocyte migration, and — with prolonged use — inhibits fibroblast proliferation, collagen deposition, and scarring [16].

The relevant observation here is that many cases clinically labeled as pathological phimosis are histologically confirmed to have chronic inflammation or early BXO lesions [18]. Kiss et al.'s 2001 RCT showed that mometasone was effective for early-to-intermediate BXO but not for late-stage disease (after irreversible tissue damage), consistent with the interpretation that the anti-inflammatory mechanism is active when inflammation is still present [19].

Mechanism 2: Skin thinning and increased elasticity

Corticosteroids suppress fibroblast collagen synthesis, inhibit epidermal proliferation, and reduce hyaluronic acid synthesis. The extracellular matrix thins; collagen and elastin fibers reorganize more densely; the skin becomes thinner and more distensible [17]. This is essentially the well-known skin-thinning side effect of prolonged topical corticosteroid use — deployed here as the intended therapeutic action.

Resolving the paradox

The paradox — steroids working on a non-inflammatory condition — dissolves partly on inspection. In clinical practice, "physiological phimosis" and early pathological phimosis are difficult to distinguish. RCT populations labeled as physiological phimosis likely contain a proportion of cases with early or subclinical BXO. Corticosteroids appear to work through different mechanisms in different subgroups:

The finding in the network meta-analysis that no significant potency difference exists [14] fits this picture: if the anti-inflammatory mechanism were dominant, higher potency would be expected to win. That it does not suggests that either mild inflammation is being addressed adequately, or that the skin-thinning mechanism operates at low potency.

Implications for retraction practice

The mechanistic picture has a bearing on the debate about gradual retraction. One proposed cycle arising from retraction practice is:

forced retraction → micro-tears at preputial ring → chronic inflammation → scarring phimosis → topical corticosteroid needed

Read this way, retraction practice may itself be generating the pathology for which corticosteroids later become the remedy. This provides mechanistic support for the "no intervention unless symptomatic, then treat with corticosteroids" algorithm.

Summary

• Physiological phimosis is not a disease. More than 99% of boys achieve full retraction by puberty without intervention.
• The mainstream position is: no intervention when asymptomatic; wash the outside only. The gradual retraction approach practiced in Japan is supported by clinical experience but lacks RCT evidence.
• Paraphimosis, recurrent inflammation, white scarring at the preputial ring, and urinary obstruction are indications to see a doctor.
• When symptoms are present, topical corticosteroids are first-line treatment; circumcision is reserved for cases where they fail.

The most evidence-consistent approach is a two-step rule: leave it alone; see a doctor if something changes.

Related Articles

• 191 Privacy and Body Autonomy at Bath Time — Navigating the transition to self-washing and body ownership
• 243 Inguinal Hernia and Undescended Testis — Two other conditions unique to male infants requiring a clinical decision
• 189 The First Signs of Puberty — The period when spontaneous foreskin retraction typically completes

References

1. Øster J. Further fate of the foreskin. Incidence of preputial adhesions, phimosis, and smegma among Danish schoolboys. Arch Dis Child. 1968;43(228):200–203. doi:10.1136/adc.43.228.200. PMID: 5650678.
2. McGregor TB, Pike JG, Leonard MP. Pathologic and physiologic phimosis: approach to the phimotic foreskin. Can Fam Physician. 2007;53(3):445–448. PMID: 17872680.
3. Hsieh TF, Chang CH, Chang SS. Foreskin development before adolescence in 2149 schoolboys. Int J Urol. 2006;13(7):968–970. doi:10.1111/j.1442-2042.2006.01437.x. PMID: 16882063.
4. Kayaba H, Tamura H, Kitajima S, Fujiwara Y, Kato T, Kato T. Analysis of shape and retractability of the prepuce in 603 Japanese boys. J Urol. 1996;156(5):1813–1815. doi:10.1016/s0022-5347(01)65544-7. PMID: 8863623.
5. UCSF Department of Urology. Phimosis — Patient information. Available from: https://urology.ucsf.edu/patient-info/children/phimosis
6. Boston Children's Hospital. Phimosis and Paraphimosis. Available from: https://www.childrenshospital.org/conditions-treatments/phimosis-and-paraphimosis
7. AboutKidsHealth (The Hospital for Sick Children). Phimosis and paraphimosis. Available from: https://www.aboutkidshealth.ca/phimosis
8. British Association of Paediatric Surgeons (BAPS). Management of foreskin conditions. 2007. Available from: https://www.baps.org.uk/wp-content/uploads/2017/03/MANAGEMENT-OF-FORESKIN-CONDITIONS.pdf
9. Japanese Society of Pediatric Urology. Phimosis [Internet]. Available from: https://jspu.jp/ippan_011.html
10. Edwards S. Balanitis and balanoposthitis: a review. Genitourin Med. 1996;72(3):155–159. doi:10.1136/sti.72.3.155. PMID: 8707315.
11. Perkins OS, Leslie SW, Cortes S. Balanoposthitis. [Updated 2024 May 6]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024–. Available from: https://www.ncbi.nlm.nih.gov/books/NBK553050/
12. Schwartz RH, Rushton HG. Acute balanoposthitis in young boys. Pediatr Infect Dis J. 1996;15(2):176–177. doi:10.1097/00006454-199602000-00020. PMID: 8822296.
13. Celis S, Reed F, Murphy F, Adams S, Gillick J, Abdelhafeez AH, et al. Balanitis xerotica obliterans in children and adolescents: a literature review and clinical series. J Pediatr Urol. 2014;10(1):34–39. doi:10.1016/j.jpurol.2013.09.027. PMID: 24295833.
14. Shanmugham S, Lee EL, Kumar S, Zuber M, Noreen N, Smales FC, et al. Effectiveness of low to moderate potency topical corticosteroids for phimosis resolution in children: results of a network meta-analysis. Int Urol Nephrol. 2025;57(1):9–17. doi:10.1007/s11255-024-04195-2.
15. Sridharan K, Sivaramakrishnan G. Topical corticosteroids for phimosis in children: a network meta-analysis of randomized clinical trials. Pediatr Surg Int. 2021;37(8):1117–1125. doi:10.1007/s00383-021-04903-4. PMID: 33860359.
16. Moreno G, Ramírez C, Corbalán J, Peñaloza B, Morel Marambio M, Pantoja T. Topical corticosteroids for treating phimosis in boys. Cochrane Database Syst Rev. 2024;1(1):CD008973. doi:10.1002/14651858.CD008973.pub3.
17. Lee CH, Lee SD. Effect of topical steroid (0.05% clobetasol propionate) treatment in children with severe phimosis. Korean J Urol. 2013;54(9):624–630. doi:10.4111/kju.2013.54.9.624. PMID: 24044097.
18. Yardley IE, Cosgrove C, Lambert AW. Paediatric preputial pathology: are we circumcising enough? Ann R Coll Surg Engl. 2007;89(1):62–65. doi:10.1308/003588407X160828. PMID: 17316525.
19. Kiss A, Csontai A, Pirót L, Nyirády P, Merksz M, Király L. The response of balanitis xerotica obliterans to local steroid application compared with placebo in children. J Urol. 2001;165(1):219–220. doi:10.1097/00005392-200101000-00064. PMID: 11125409.